Global Precision Medicine Market is Register CAGR 12.71% Growth during 2018-2023
A recent study on Precision Medicine Market by KD Market Insights provides analysis of various factors that can affect the market share. The titled report " Precision Medicine Market: Market Size, Trends, Share & Forecast 2018-2023 " broadly covers the analysis of key market drivers, challenges and trends and gives a better understanding about the forces that shape competition within the industry.
Precision medicine is an upcoming approach which involves investigating whether a person has any diseases by evaluating the genetic makeup, and then diagnosing it. According to Netscribes, the global precision medicine market is expected to have a significant compounded annual growth rate (CAGR) of 12.71% and have a market size in excess of USD 96.07 Bn by 2023. North America dominates the global market due to the high incidence of cancer and increasing government initiatives in the region.
Request for Sample @ https://www.kdmarketinsights.com/sample/3187
The report begins with an overview for Precision Medicine Market. The research report broadly covers analysis of key market drivers, challenges, opportunities and trends. The study also provides separate analysis to understand market size, projections and macroeconomic indicators of global regions that affects the market share. The report also offers an extensive coverage of various industry players along with their recent product launches and market activities. The report also goes through porter’s five analyses for getting a better understanding about the forces that shape competition within the industry. There is a timeline considered for useful analysis i.e. 2017 is considered as base year, 2018 as estimated year and 2019-2023 as forecasted year.
The research also does a separate geographical analysis that comprises both the region wise and country wise analysis. The geography covered in the report is North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe) , Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific) Latin America (Brazil, Mexico, Argentina and Rest of Latin America) and Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa). As per the report, Asia Pacific is likely to be the market giant in the upcoming years.
Considering the competition, the major vendors providing Precision Medicine Market across the globe are – Abbott Laboratories, GE Healthcare, GlaxoSmithKline (GSK), Johnson & Johnson, Pfizer, Laboratories Corporation of America Holdings and Danaher Corporation, among others.
These vendors have adopted various types of organic and inorganic growth strategies, such as new product launches, business expansions, partnerships and collaborations, and mergers and acquisitions, to expand their offerings and further expand their presence in the Precision Medicine Market.
Browse Full Report With TOC@ https://www.kdmarketinsights.com/product/global-precision-medicine-market
Table of Content
Chapter 1: Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive Summary
Chapter 2: Global precision medicine market - market overview
2.1. Global market overview - market trends, market attractiveness analysis, geography-wise market revenue (USD)
2.2. Global market drivers and challenges
2.3. Value chain analysis – precision medicine market
2.4. Porter’s Five Forces Analysis
2.5. Market size based on ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies)
2.5. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.5. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. Market size based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases)
2.6. a. Revenue from cancer therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. b. Revenue from cardiovascular therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. c. Revenue from central nervous system therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. d. Revenue from psychiatric disorder therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.6. e. Revenue from infectious diseases therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. Market size based on technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics)
2.7. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. d. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
2.7. e. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
Chapter 3: North America precision medicine market - market overview
3.1. Market overview - market trends, market attractiveness analysis, geography wise market revenue (USD)
3.2. North America - market drivers and challenges
3.3. Market size based on ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies)
3.3. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. Market size based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases)
3.4. a. Revenue from cancer therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. b. Revenue from cardiovascular therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. c. Revenue from central nervous system therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. d. Revenue from psychiatric disorder therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.4. e. Revenue from infectious diseases therapeutics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.5. Market size based on technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics)
3.5. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
Continue....
Check for Discount @ https://www.kdmarketinsights.com/discount/3187
About KD Market Insights
KD Market Insights has come with the idea of helping business by intelligent decision making and thorough understanding of the industry. We offer a comprehensive database of syndicated research, customized reports as well as consulting services to help a business grow in their respective domain. At KD Market Insights, we offer our client a deep Market research reports accompanied by business consulting services that can help them to reach on top of the corporate world. Our customized reports are built by keeping all factors of the industry in mind.
Contact Us
150 State Street, 3rd Floor,
Albany, New York
United States (12207)
Telephone: +1-518-300-1215
Email: - [email protected]
Website: - www.kdmarketinsights.com